US2017342111A1PendingUtilityA1

Markers for the Diagnosis of Celiac Disease

45
Assignee: SKRINER KARLPriority: Oct 1, 2009Filed: Nov 20, 2015Published: Nov 30, 2017
Est. expiryOct 1, 2029(~3.2 yrs left)· nominal 20-yr term from priority
Inventors:Karl Skriner
G01N 33/581G01N 33/543G01N 33/6854G01N 33/564C07K 14/00G01N 33/68G01N 33/6893C07K 14/415G01N 2800/06
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to isolated antibodies that bind to specific peptides and to their use in the diagnosis of celiac disease.

Claims

exact text as granted — not AI-modified
1 . An isolated antibody that binds to a peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 and/or SEQ ID NO: 4. 
     
     
         2 . Method for the detection of pathogens associated with celiac disease, preferably in foods, comprising the steps of:
 i) a sample is contacted in vitro with the isolated antibody of  claim 1 , and   ii) detecting binding of the isolated antibody to a pathogen in the sample, thereby detecting said pathogen.   
     
     
         3 . A kit for performing the method of  claim 2 , wherein said kit comprises the isolated antibody of  claim 1 . 
     
     
         4 . The kit of  claim 3 , wherein the isolated antibody of  claim 1  is immobilized on a support. 
     
     
         5 . The kit according to  claim 3 , wherein the kit is in the form of an ELISA or strip test.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.